Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis.

MLA

Park, Yong-Jin, et al. “Prognostic Value of Pretherapeutic FDG PET/CT in Non-Small Cell Lung Cancer with Pulmonary Lymphangitic Carcinomatosis.” Scientific Reports, vol. 13, no. 1, Jan. 2023, p. 345. EBSCOhost, https://doi.org/10.1038/s41598-022-24875-2.

APA

Park, Y.-J., Im, Y., Kwon, O. J., Han, J., Ahn, M.-J., Kim, J., Um, S.-W., & Choi, J. Y. (2023). Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis. Scientific Reports, 13(1), 345. https://doi.org/10.1038/s41598-022-24875-2

Chicago

Park, Yong-Jin, Yunjoo Im, O Jung Kwon, Joungho Han, Myung-Ju Ahn, Jhingook Kim, Sang-Won Um, and Joon Young Choi. 2023. “Prognostic Value of Pretherapeutic FDG PET/CT in Non-Small Cell Lung Cancer with Pulmonary Lymphangitic Carcinomatosis.” Scientific Reports 13 (1): 345. doi:10.1038/s41598-022-24875-2.